Brief: Simcere Pharmaceutical Says Unit To Buy Entire Stake In Target Company For RMB30.8 Million
25/03/2026 15:27
March 25 (Reuters) - Simcere Pharmaceutical Group Ltd 2096.HK: UNIT TO BUY ENTIRE STAKE IN TARGET COMPANY FOR RMB30.8 MILLION TARGET CO REFERS TO SHANGHAI SIMCERE DIAGNOSTIC TECHNOLOGY Further company coverage: 2096.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Simcere Pharmaceutical
See all newsBrief: Simcere Pharmaceutical Announces Approval For Marketing Of Yingmule In China By NMPA
Simcere Pharmaceutical jumps most in two months on Roche tie-up
Roche signs global licensing pact for Simcere's experimental blood cancer drug (updated)
Roche signs global licensing pact for Simcere's B-cell cancer drug candidate
Brief: Simcere Pharmaceutical Enters Exclusive Global Licensing Agreement With Roche For SIM0660